Navigation Links
Baxa Corporation Demonstrates End-to-End Environmental Stewardship
Date:4/22/2011

ENGLEWOOD, Colo., April 22, 2011 /PRNewswire/ -- In conjunction with Earth Day 2011, Baxa Corporation today announced its continued strides to reduce the environmental impact of business operations – from manufacturing efficiency to packaging design and office processes.

Since 2008 the company's recycling initiatives have grown by 22 percent; and in 2010 alone its comprehensive program contributed nearly 100 tons of single-stream recycling. This significant achievement reduced the consumption of:

  • 45,527 gallons of oil;
  • 2,360 gallons of gasoline; and
  • 688,310 gallons of water.

"As with patient safety, we recognize environmental conservation is a way of life, or a set of behaviors. Last year, we saved more water than it takes to fill an Olympic-size swimming pool. Achieving real results like that means something to our organization," stated Greg Baldwin, Chairman and CEO of Baxa.

"Our focus on the reduced use of resources permeates all that Baxa does. In fact, we just reconfigured our ExactaMix® disposables packaging to a more compact design to reduce the storage requirements and waste burden," continued Baldwin. "As a practitioner of the lean manufacturing philosophy, we support lean pharmacy objectives with our partners and customers as well."

Charting an Environmental Course

Baxa strives to foster a culture of environmental stewardship, both for itself and its network of customers. In 1999 the company adopted lean manufacturing principles to reduce waste and scrap in production. Then, in 2002, the company built its state-of-the-art manufacturing plant to increase efficiency in lighting, air handling and process control.

The Baxa environmental perspective extends beyond the walls of its LEED® silver-certified headquarters, as the DoseEdge® pharmacy workflow management system works to minimize pharmacy waste. Of the nearly 4,000 active DoseEdge users, more than 41,000 doses have been reused since the product's inception – a direct result of its waste reduction capabilities.

Recently Allegheny General Hospital, a 661-bed facility in Pennsylvania, conducted a study to reduce the volume of discarded IV doses. The results, which were presented at the 2010 ASHP Midyear Clinical Meeting, highlighted the role DoseEdge played in the dramatic reduction of IV waste volume. In just eighteen months the hospital slashed its annualized number of wasted doses by 69 percent. This marks a reduction of 22,995 doses. According to the research, Allegheny's coordinated approach to waste reduction translated to an annualized savings of $310,000.

Directors of Pharmacy and industry professionals can discover more about minimizing waste in the pharmacy by attending the upcoming educational webinar, "Implementation of Dose Management Tools and the Impact on Sterile Product Waste." This free event will be held July 27th and be led by Dennis Killian PharmD, PhD, Director of Pharmacy Services at Peninsula Regional Medical Center and Associate Professor, University of Maryland Eastern Shore School of Pharmacy. For more information and to register visit www.baxa.com/webinars.

For more information about Baxa Corporation, visit www.baxa.com or call 800.567.BAXA.

About Baxa Corporation

Baxa, a customer-focused medical device company, provides innovative, solution-based technologies for medication handling and delivery. Its systems and devices promote the safe and efficient preparation, handling, packaging and administration of medications. Key products used worldwide in hospitals and healthcare facilities include: the Abacus® Order Entry and Calculation Software, the DoseEdge® Pharmacy Workflow Manager, ExactaMed® Oral Syringes, ExactaMix® Automated Compounding Devices, InFuse™ and MicroFuse® Syringe Infusers, Repeater™ Pharmacy Pumps, NeoThrive® Enteral Syringes, the PadLock®  Set Saver and the RapidFill™ and IntelliFill® i.v. Automated Syringe Fillers. Privately held, Baxa Corporation has subsidiaries and sales offices in Florida, Canada and the United Kingdom; direct representation in Austria, Belgium, Denmark, Finland, France, Germany, Italy, Luxembourg, The Netherlands and Switzerland; and distribution partners worldwide. Further information is available at www.baxa.com.

Contact:
Marian Robinson, Vice President, Marketing
Baxa Corporation:  800.567.2292 ext. 2157 or 303.617.2157
Email:  marian.robinson@baxa.com

Perrin McCormick or Brandie Gerrish
HB | Hart-Boillot: 781.893.0053
Email: baxa@hbagency.com


'/>"/>
SOURCE Baxa Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cardiogenesis Corporation to Report 2011 First Quarter Results on May 4th
2. Awarepoint Corporation Announces Acquisition of PCTS
3. Luminex Corporation First Quarter Earnings Release Scheduled for May 9, 2011
4. CryoLife Announces Expiration of Go-Shop Period Related to its Proposed Acquisition of Cardiogenesis Corporation
5. Altitude Organic Corporation Opens DoctorMMJ.com Physician Referral Service in Scottsdale, Arizona
6. Oxford Finance Corporation Provides a $2 Million Equipment Facility to Synta Pharmaceuticals Corp.
7. Kensey Nash Corporation Announces Its Third Quarter Fiscal Year 2011 Earnings Release Date and Teleconference
8. Sanofi-Aventis Completes Acquisition of Genzyme Corporation
9. Biofield Corporations 51% Owned Subsidiary Agrees to Deal Appointing McKinley Infocapital as Korean Exclusive Distributor of Breast Cancer Diagnostic System; Contract has Potential Value of up to $15.3 Million
10. Luminex Corporation Wins Prestigious Medical Design Excellence Award
11. Vystar® Corporation Appoints Joanne Kearney as Vice President of Marketing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... , January 19, 2017 ... administration appears serious about reducing the FDA,s regulatory ... innovation in the medical drug industry, many of ... with new clinical trials and development of advanced ... forging ahead with recent developments include:  Moleculin Biotech, ...
(Date:1/19/2017)... 2017  Magnetic Insight Inc., leader in magnetic ... agreement with inviCRO LLC to develop intuitive image ... based on inviCRO,s VivoQuant™ visualization and post processing ... complete MPI solution package with the Momentum MPI ... imaging in vivo. MPI is a ...
(Date:1/18/2017)... 18, 2017  EnteroMedics Inc. (NASDAQ: ... neuroblocking technology to treat obesity, metabolic diseases and ... an underwritten public offering of units for gross ... discounts and commissions and offering expenses payable by ... Class A Units, priced at a public offering ...
Breaking Medicine Technology:
(Date:1/19/2017)... ... 2017 , ... Tribble Insurance Agency, a family owned and operated firm offering ... charity event to honor Chad Phillip Dermyer, a local police trooper who was shot ... and his fellow officers were conducting routine stops of suspects when one of them, ...
(Date:1/19/2017)... ... January 19, 2017 , ... For the second consecutive year, ... Connecticut (RMACT) have earned “Top Doctor” awards. Dr. Mark Leondires, Dr. Spencer Richlin, ... been chosen by their peers for the 2017 list based on their exceptional ...
(Date:1/19/2017)... ... January 19, 2017 , ... Sales Focus Inc. (SFI), a Maryland-based sales ... market. , Over the past 20 years SFI has been recognized as the world’s ... six new clients into the US market. The new clients include: Panacea Pro, ...
(Date:1/19/2017)... ... January 19, 2017 , ... Fillers are known ... Few people know that popular cosmetic fillers can enhance earlobes and ... medical director of the MilfordMD Cosmetic Dermatology Surgery & Laser Center, in Milford, ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... of Bioengineering are collaborating on a research project focused on multiple sclerosis (MS). ... seeks to use nanotechnology to control the disease without compromising normal immune function ...
Breaking Medicine News(10 mins):